

– LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after – – Continued favorable safety profile observed in masked Phase 3 DURAVYU data, consistent with four previously completed clinical trials – – All active patients in the treatment arm have reached their second DURAVYU dosing visit, with over 35% receiving a third dose – WATERTOWN, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that the independent Data Safety Monitoring Committee (DSMC) completed its third scheduled review of the Company's pivotal Phase 3 program evaluating DURAVYU for wet age-related macular degeneration (wet AMD) and recommended that both the LUGANO and LUCIA trials continue as planned with no protocol modifications.

An SEC filing on July 2, 2025, showed Crumly & Associates sold 155,440 shares of Distillate Small/Mid Cash Flow ETF (DSMC 1.82%), totaling $4.98 million in transaction value. After the trade, the fund's remaining stake in Distillate Small/Mid Cash Flow ETF was worth $1.04 million, according to the 13F report.

DSMC is a small/mid-cap cash flow ETF focusing on quality and value factors with unique selection criteria. Its ER is 0.55% and the fund has $104 million in assets. My analysis reveals substantially better quality metrics compared to the Russell 2000 Value ETF almost across the board. DSMC's 12.46x forward P/E is particularly appealing. However, other cash-flow-based ETFs like CALF, SFLO, and SMCF arguably have better fundamentals. DSMC's constituents also have negative earnings growth, which explains why it's lagged YTD.

Investing in stocks with the mindset of a company owner is what's given some of Distillate Capital's best ETFs an edge. The post These ETFs Help You Invest Like An Owner, Not A Speculator appeared first on Investor's Business Daily.

Distillate Capital, a fundamentals-driven equity manager focused on delivering highly differentiated risk-managed value investing strategies, today announced the launch of the Distillate Small/Mid Cash Flow ETF (NYSE Arca: DSMC), the newest addition to the firm's ETF lineup built around the firm's measures of quality, risk, and value as seen through the lens of free cash
SEC filings for DSMC aren't indexed yet — common for recently launched funds. Browse the issuer's filings on SEC EDGAR directly.